Search research articles
Contact Us
Filters
Showing results (101-110 of 351) with videos related to
Page
of 36
Sort By:
Nature Reviews. Cancer
|
July 25, 2015
Evolving synergistic combinations of targeted immunotherapies to combat cancer
Ignacio Melero, David M Berman, M Angela Aznar, et al.
Experimental Hematology
|
March 8, 2002
Upregulation of natural killer cells functions underlies the efficacy of intratumorally injected dendritic cells engineered to produce interleukin-12
Mercedes Rodríguez-Calvillo, Marina Duarte, Iñigo Tirapu, et al.
Cancer Discovery
|
September 4, 2025
The Dark Side of NK Cells in Cancer Immunotherapy
Felipe Galvez-Cancino, Maria Armero, David R Withers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 3, 2010
Immunology and gene therapy: shoulder to shoulder into the fray
Cristian Smerdou, Carmen Ochoa, Jose I Quetglas, et al.
Oncoimmunology
|
June 23, 2017
Cellular immunotherapies for cancer
Pedro Berraondo, Sara Labiano, Luna Minute, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 28, 2012
Immunotherapeutic synergy between anti-CD137 mAb and intratumoral administration of a cytopathic Semliki Forest virus encoding IL-12
José I Quetglas, Juan Dubrot, Jaione Bezunartea, et al.
International Review of Cell and Molecular Biology
|
July 7, 2022
Killers on the loose: Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatment
Cordelia Dunai, Erik Ames, Maria C Ochoa, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 1, 2020
Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
Elisabeth Pérez-Ruiz, Ignacio Melero, Joanna Kopecka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2023
Facts and Hopes on Neutralization of Protumor Inflammatory Mediators in Cancer Immunotherapy
Irene Olivera, Carlos Luri-Rey, Alvaro Teijeira, et al.
Frontiers in Immunology
|
December 8, 2018
CD137 (4-1BB) Signalosome: Complexity Is a Matter of TRAFs
Juan M Zapata, Gema Perez-Chacon, Pablo Carr-Baena, et al.
Page
of 36
Search research articles
Search
Showing results (101-110 of 351) with videos related to
Sort By:
Page
of 36
Nature Reviews. Cancer
|
July 25, 2015
Evolving synergistic combinations of targeted immunotherapies to combat cancer
Ignacio Melero, David M Berman, M Angela Aznar, et al.
Experimental Hematology
|
March 8, 2002
Upregulation of natural killer cells functions underlies the efficacy of intratumorally injected dendritic cells engineered to produce interleukin-12
Mercedes Rodríguez-Calvillo, Marina Duarte, Iñigo Tirapu, et al.
Cancer Discovery
|
September 4, 2025
The Dark Side of NK Cells in Cancer Immunotherapy
Felipe Galvez-Cancino, Maria Armero, David R Withers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 3, 2010
Immunology and gene therapy: shoulder to shoulder into the fray
Cristian Smerdou, Carmen Ochoa, Jose I Quetglas, et al.
Oncoimmunology
|
June 23, 2017
Cellular immunotherapies for cancer
Pedro Berraondo, Sara Labiano, Luna Minute, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 28, 2012
Immunotherapeutic synergy between anti-CD137 mAb and intratumoral administration of a cytopathic Semliki Forest virus encoding IL-12
José I Quetglas, Juan Dubrot, Jaione Bezunartea, et al.
International Review of Cell and Molecular Biology
|
July 7, 2022
Killers on the loose: Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatment
Cordelia Dunai, Erik Ames, Maria C Ochoa, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 1, 2020
Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
Elisabeth Pérez-Ruiz, Ignacio Melero, Joanna Kopecka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2023
Facts and Hopes on Neutralization of Protumor Inflammatory Mediators in Cancer Immunotherapy
Irene Olivera, Carlos Luri-Rey, Alvaro Teijeira, et al.
Frontiers in Immunology
|
December 8, 2018
CD137 (4-1BB) Signalosome: Complexity Is a Matter of TRAFs
Juan M Zapata, Gema Perez-Chacon, Pablo Carr-Baena, et al.
Page
of 36